PERFECT MEDICAL (01830) has issued an announcement. Based on the preliminary assessment by the company's management of the unaudited consolidated management accounts of the company and its subsidiaries (the Group) for the six months ended September 30, 2026 (the current period), the Group is expected to record profit attributable to shareholders of approximately HK$142 million to HK$147 million for the current period, representing a significant increase of approximately 50% to 55% compared with the same period in 2025.
The expected substantial increase in profit is mainly attributable to the following reasons: Digital transformation unlocking cost efficiencies and scalability — management has accelerated the digitalization of the business and streamlined processes, comprehensively optimizing the cost structure, strengthening operating leverage, and building a more scalable platform for sustainable growth.
Streamlined network delivering stronger operating leverage — the Group has continued to optimize its service mix and network layout, and has systematically consolidated lower-productivity service centers, thereby enhancing overall operating efficiency and profitability, laying the foundation for better returns when demand recovers.
Overseas markets gradually stabilizing and showing improving momentum — operations in Australia, Singapore, and Macau have gradually stabilized, with profitability improving, benefiting from disciplined network adjustments and an asset-light operating model. This provides a solid foundation for further expansion when market conditions improve.
Comments